JPRN-UMIN000044973尚未招募未知
A single-center prospective study on the safety of endobiliary radiofrequency ablation of hilar malignant biliary stenosis - Safety of endobiliary RFA for hilar malignant biliary stenosis
Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate school of Medicine0 个研究点目标入组 20 人开始时间: 2021年7月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients in whom the endoscope cannot reach the duodenal papilla 2.Patients with jaundice or cholangitis that cannot be controlled by biliary drainage 3.Patients with serious complications in other organs: ASA classification of 3 or higher 4.Patients with a life expectancy of less than 3 months 5.Patients with a history of surgical gastrointestinal reconstruction 6.Patients with significant invasion of the hepatic artery by the tumor 7.Patients who are deemed inappropriate by the researcher
研究者
相似试验
尚未招募
不适用
A single centre prospective study on the safety and efficacy of per oral endoscopic myotomy (POEM) in the endoscopic management of achalasia and other oesophageal motility disorderAchalasiaEsophageal Motility DisorderOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonSurgery - Surgical techniquesACTRN12619001011178Royal Adelaide Hospital50
尚未招募
不适用
A prospective study on the efficacy and safety of double stenting with a narrow covered self-expandable metallic stent (SEMS) for malignant distal bile duct stenosisJPRN-jRCT1052210158Shiomi Hideyuki20
进行中（未招募）
不适用
An Open-label, Multi-centre Study of the Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine (ProQuad®) Manufactured with Recombinant Human Albumin (rHA) when administered to Children in their Second Year of LifeCombined Measles, Mumps, Rubella and Varicella Live VaccineMedDRA version: 9.1Level: LLTClassification code 10000639Term: Active immunisationMedDRA version: 9.1Level: LLTClassification code 10039242Term: Routine childhood immunisationMedDRA version: 9.1Level: LLTClassification code 10036897Term: Prophylactic vaccinationEUCTR2007-002438-12-SESanofi Pasteur MSD S.N.C.3,340
进行中（未招募）
1 期
An Open-label, Multi-centre Study of the Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine (ProQuad®) Manufactured with Recombinant Human Albumin (rHA) when administered to Children in their Second Year of LifeEUCTR2007-002438-12-GRSanofi Pasteur MSD S.N.C.3,388
进行中（未招募）
1 期
An Open-label, Multi-centre Study of the Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine (ProQuad®) Manufactured with Recombinant Human Albumin (rHA) when administered to Children in their Second Year of LifeCombined Measles, Mumps, Rubella and Varicella Live VaccineMedDRA version: 9.1Level: LLTClassification code 10000639Term: Active immunisationMedDRA version: 9.1Level: LLTClassification code 10039242Term: Routine childhood immunisationMedDRA version: 9.1Level: LLTClassification code 10036897Term: Prophylactic vaccinationEUCTR2007-002438-12-DKSanofi Pasteur MSD S.N.C.3,388